Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Apr 23, 2016 5:43pm

129 Views

Post# 24802968

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lots of volume on Taimed and SP slidding

Spceo ,

not an answer to my question . We are here to help eachother and i surely appreciate your input . I am long term holder and can only hope for the best. But i am not putting any hope on Ibalizumab because no intrest of big pharma . So i do hope they can build the co on Egrifta like you told before we knew about Ibalizumab . Your thougts ? Really appreciated !

Glty

Bullboard Posts

The top 10 Canadian medical stocks